Nutriband (NASDAQ:NTRB) Shares Down 0.8% – Here’s Why

Nutriband Inc. (NASDAQ:NTRB)’s share price dropped 0.8% during mid-day trading on Friday. The company traded as low as $6.00 and last traded at $6.22. 27,919 shares traded hands during mid-day trading, a decline of 78% from the average session volume of 127,966 shares. The stock had previously closed at $6.27.

Analysts Set New Price Targets

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Nutriband in a report on Monday, September 28th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Reduce”.

Nutriband Price Performance

The stock’s 50-day simple moving average is $5.86 and its two-hundred day simple moving average is $4.28. The firm has a market capitalization of $75.64 million, a P/E ratio of -11.74 and a beta of 1.92.

Nutriband (NASDAQ:NTRB) last released its quarterly earnings data on Friday, September 4th. The company reported ($0.07) earnings per share (EPS) for the quarter. The company had revenue of $0.44 million for the quarter. Nutriband had a negative net margin of 430.35% and a negative return on equity of 109.07%.

Nutriband Company Profile

Nutriband Inc (NASDAQ:NTRB) develops and manufactures transdermal patches and other wearable drug-delivery products for pharmaceutical, over-the-counter, consumer, and wellness markets. The company’s capabilities include product development, formulation, manufacturing, packaging, and private-label services for customers seeking patch-based delivery systems.

Nutriband’s portfolio includes consumer and wellness patches, as well as prescription-focused transdermal technologies. Its AVERSA platform is designed to incorporate abuse-deterrent features into transdermal products, with the goal of helping reduce the risk of drug extraction, misuse, or abuse.